Data / Form D filings / Par Health, Inc.
Par Health, Inc.: Form D filing
Par Health, Inc., a pharmaceuticals company in St. Louis, MO, filed a Form D with the SEC in 2025. The latest, on November 25, 2025, reports $763 million sold of a $763 million offering to 234 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 675 James S. McDonnell Blvd., St. Louis, MO, 63042
- Phone
- (314) 654-2000
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 2096530
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | New notice | $763,000,000 | $763,000,000 | 234 | Nov 10, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Teresa Sanzottera | Executive Officer | |
| Jake Longenecker | Executive Officer | |
| Jeffrey Wiegers | Executive Officer | |
| Scott Sims | Executive Officer | |
| Mick McGuinness | Executive Officer | |
| Kass Harrold | Executive Officer | |
| Matthew Stober | Director | |
| Michael Heffernan | Director | |
| Joshua Murray | Director | |
| Stephen Welch | Executive Officer, Director | |
| Jonathan Zinman | Director | |
| Matthew Maletta | Executive Officer | |
| Jack Boyle | Executive Officer | |
| Andrew Gonce | Executive Officer |
Other pharmaceuticals companies in Missouri that filed recently
- Immunophotonics, Inc. $10.1 million · Sep 4, 2026
Every Form D from the week of Nov 24, 2025 · All recent filings in Missouri · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Par Health, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.